Integra LifeSciences | IART - Assets


Integra LifeSciences reported $3.65B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
CONMED USD 2.33B 3.26M Dec/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Globus Medical USD 5.3B 207.12M Dec/2025
HeartBeam USD 2.88M 3.1M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 91.35B 374M Sep/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Orthofix International USD 832.61M 4.55M Sep/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 7.87B 496.72M Sep/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025